Pep is a medical tracking app for GLP-1 medication users, providing injection reminders, nutrition logging, and progress visualization on iOS and Android.
Product velocity
Active
Daily rank 🇺🇸
#51
Medical · grossing
Sentiment
4.6
2k reviews
Nemesis
Medisafe Medication Management
The App DNA
What makes this app unique?
Users hire Pep to manage the high-stakes, multi-step requirements of GLP-1 treatment in one place, reducing the cognitive load of tracking medication, side effects, and nutrition simultaneously.
For Individuals prescribed GLP-1 medications for weight loss who require a centralized tool for medication adherence, nutrition tracking, and progress monitoring.
What does it look like?
Key features
Logs injectable and oral medication doses including Ozempic, Wegovy, Mounjaro, and Zepbound
Uses photo and barcode recognition to estimate calories, protein, and fiber via FatSecret API
Prompts users to alternate injection locations to prevent tissue damage
How much does it cost?
Freemium model uses a free-to-download entry point with a premium gate for advanced nutrition and progress analytics.
Velocity
Active developmentnew contentUX improvementsperformanceShow more...
The app maintains an active development cadence, shipping 5 updates over the last 75 days, averaging approximately 0.46 releases per week. Development is focused on feature parity across platforms, specifically regarding the integration of GLP-1 injection and pill tracking. While the release notes for recent updates are somewhat repetitive, the consistent frequency indicates a stable development cycle focused on feature refinement and performance optimization. The trend is stable, with no signs of deceleration.
Who built it?
Shred Apps
13+ apps tracked · Medical
Stew Smith's Push-Up Push
Gym Workout Planner For Women
Navy SEAL Training & Exercises
Gym Workout For Men
Big Butt & Leg Workout Planner
Abs Workout – Men
Home HIIT Workout For Women
Home Workout For Women
Josh Hopkins Fitness
Home Workout No Equipment.
DamenGFit
Gym HIIT Workout for MenUser Sentiment
What do users think recently?
The recent review mood reads mixed. Users appreciate comprehensive tracking of glp-1 medication and progress metrics keeps users focused on their health goals, but report inaccurate ai meal calorie estimation poses potential health risks for users tracking weight loss.
How are ratings & reviews evolving?
What users say, by theme
- Comprehensive tracking of GLP-1 medication and progress metrics keeps users focused on their health goals
- Inaccurate AI meal calorie estimation poses potential health risks for users tracking weight loss
64 of 112 recent reviews analyzed · high confidence · Mixed overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for GLP-1 Tracker: Pep
How's the Medical market?
Pep currently holds a #64 Grossing position in the US Medical category. The gap between its utility-driven free user base and its grossing rank indicates that the premium gate for AI nutrition features is not yet converting at scale.
Read the market outlookThe rivals identified
By MediSafe Inc.
Directly competes on the core job-to-be-done of medication adherence and complex reminder scheduling for chronic conditions.
- Integrates comprehensive drug-to-drug interaction warnings that go beyond simple shot reminders
- Supports family caregiver accounts allowing multiple users to manage a single patient's medication schedule
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for GLP-1 Tracker: Pep
Where is it heading?
The GLP-1 tracking market is consolidating around tools that offer clinical-grade reliability, leaving Pep exposed to churn if its AI-driven features continue to underperform. The PM must pivot from feature-heavy updates to stability-first engineering to prevent users from migrating to more established medical-management platforms.
- Technical regressions in the latest update break dosage logging, which directly erodes the daily habit and increases churn risk.
- Recent updates focused on stability and oral pill support, indicating a shift toward maintaining core utility over aggressive feature expansion.
The SWOT
- Centralized GLP-1-specific workflow reduces user cognitive load
- Injection site rotation tracking creates specialized health-safety switching costs
- Integration with wearable devices would automate biometric data
- Expansion into professional-grade PDF reporting for endocrinologists
Next best moves
The counter-intuitive read
The reliance on AI food scanning is a strategic liability, not a differentiator…
Read the full takeFeature gaps
Clinical-grade drug-to-drug interaction warnings (available in Medisafe) +2
Since the last report: The app expanded its medication support to include oral pills but faces declining user sentiment due to technical instability, billing friction, and inaccurate AI meal logging.
Bottom line
Pep succeeds by centralizing GLP-1 adherence, but technical instability and AI inaccuracy threaten its retention, so the PM must prioritize core data reliability over new feature expansion to stabilize the user base.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated